CHRISTINE OLSON: Open Payments
NPI 1396039947 · ANCHORAGE, AK. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$187 in 8 payments from 8 companies in 2025. Trend: 2023 $236 · 2024 $108 · 2025 $187
Food & beverage: $187
| Company | Payments | Amount |
|---|---|---|
| Travere Therapeutics, Inc. | 1 | $31 |
| Novartis Pharmaceuticals Corporation | 1 | $30 |
| Ascendis Pharma Endocrinology Inc | 1 | $29 |
| Alexion Pharmaceuticals, Inc. | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Lilly USA, LLC | 1 | $20 |
| AKEBIA THERAPEUTICS INC | 1 | $14 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $13 |
Products named: Yorvipath, ULTOMIRIS, VOYXACT, MOUNJARO, Vafseo, Kerendia.
Industry payments across AK — which companies pay providers there.
